Zurueck zur Suche

Reporte zur Charge U022983

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

16Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TX 4 IL 4 MN 2 FL 2 OH 1 TN 1 NY 1 MD 1

VAERS 2680413

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022983

mild
Staat
OH
Alter
4,0
Geschlecht
F
Eingang
08.09.2023
Impfdatum
21.07.2023
Beginn
02.08.2023
Tage bis Beginn
12,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Immunisation reaction Pyrexia Rash

Symptomtext

Fever 102.8 on 8/2/2023, fever 100.8 on 8/3/2023, rash developed on 8/2/2023 to nose and face, and then down arms and chest, mother notes no seizure activity noted

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
Mother notes child seen by family PCP; Dr., mother notes physician reports an adverse reaction to MMRII, but ok to get additional dose
Aktuelle Erkrankungen
none
Vorgeschichte
mother notes child has hx of seizures
Andere Medikamente
n/a
Allergien
none
Vorherige Impfungen
-

VAERS 2476205

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022983

mild
Staat
TX
Alter
41,0
Geschlecht
F
Eingang
12.10.2022
Impfdatum
10.10.2022
Beginn
11.10.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Back pain Dry throat Musculoskeletal stiffness

Symptomtext

Stiffness of the neck, back pain , dryness of the throat

Weitere VAERSDATA-Felder
Praegender Schweregrund
Back pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Asthma
Andere Medikamente
Singulair 10mg
Allergien
-
Vorherige Impfungen
-

VAERS 2405756

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022983

mild
Staat
MN
Alter
1,0
Geschlecht
F
Eingang
09.08.2022
Impfdatum
09.08.2022
Beginn
09.08.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site swelling Laboratory test

Symptomtext

swelling/redness at sight was in lab they sent her over to the ER. Dr who she had seen for a well child that day was notified and went and checked on patient as well as the RN. Patient and mother were brought back up to clinic and monitored for about 30 mins longer. RN drew labs. Provider said patient was just fine and well. Patient left with mother.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
Patient had Fluoride Varnish 5% administered on teeth prior to vaccinations
Allergien
n/a
Vorherige Impfungen
-

VAERS 2402836

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022983

mild
Staat
FL
Alter
4,0
Geschlecht
M
Eingang
05.08.2022
Impfdatum
04.08.2022
Beginn
05.08.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Cough Rash Rash maculo-papular Respiratory tract congestion Somnolence

Symptomtext

Had small maculopapular rash all over hisbody coughing and congestion and drowsiness.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
N/A-- Patient was sent to ER maybe test were done there but not in the office
Aktuelle Erkrankungen
None that are known of
Vorgeschichte
Sickle cell Trait
Andere Medikamente
No
Allergien
NKA
Vorherige Impfungen
-

VAERS 2686967

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022983

gering
Staat
IL
Alter
-
Geschlecht
U
Eingang
27.09.2023
Impfdatum
18.07.2023
Beginn
18.07.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no adverse event; patient received improperly stored vaccine; This spontaneous report as received from a physician refers to a patient of unknown age and gender. On 18-JUL-2023, the patient was vaccinated with an improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (lot # U022983 exp date 22-JUL-2023) (dose and route not reported). The temperature of excursion was 49.3?F for a time frame of 3 hour 11 minutes. There was no previous temperature excursion.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2676238

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022983

gering
Staat
IL
Alter
-
Geschlecht
U
Eingang
24.08.2023
Impfdatum
03.08.2023
Beginn
03.08.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Nurse reported MMRII was administered after improper storage; MMRII Lot: U022983 Exp: 07/22/2023; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies, concurrent conditions and concomitant medications were not reported. On 03-AUG-2023, the patient was vaccinated with improperly stored and also expired measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) 1 dose, recombinant Human albumin (rHA) lot # U022983 with expiration date 22-JUL-2023, for prophylaxis (strength and route of administration were not provided). The vaccine was exposed to a temperature of 51?F for 1 hour. No previous temperature excursion was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2670986

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022983

gering
Staat
TX
Alter
-
Geschlecht
U
Eingang
14.08.2023
Impfdatum
02.08.2023
Beginn
02.08.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE/PQC; patient was inadvertently administered an expired dose of MMR II.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 02-AUG-2023, the patient was inadvertently vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live, recombinant human albumin (rHA) (M-M-R II), 0.5 milliliter, lot #U022983, expiration date: 22-JUL-2023 (strength, dosage regimen, anatomical location, and route of administration were not provided) as prophylaxis. No adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2662809

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022983

gering
Staat
TX
Alter
17,0
Geschlecht
M
Eingang
28.07.2023
Impfdatum
31.05.2023
Beginn
31.05.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event

Symptomtext

HCP calling to report a child was inadvertently administered a third dose of MMRII and a third dose of VARIVAX. The patient has had no side effects. No further information provided. No additional AE/PQC.; HCP calling to report a child was inadvertently administered a third dose of MMRII and a third dose of VARIVAX. The patient has had no side effects. No further information provided. No additional AE/PQC.; This spontaneous report was received from a registered nurse referring to 17-year-old male patient. The patient's concurrent condition, and medical history were not provided. Concomitant medication included sterile diluent. On 31-MAY-2023, the patient was inadvertently administered a third dose of measles, mumps, and rubella (Wistar RA 27-3) virus vaccine, live (recombinant human albumin [rHA]) (M-M-R II) injection 0.5 mL (route of administration and anatomical location not provided; lot# U022983, expiry date: 22-JUL-2023) and a third dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) injection 0.5 mL (route of administration and anatomical location not provided; lot# U029621, expiry date: 22-SEP-2023) as prophylaxis (extra dose administered). The patient had no side effects and there was no additional adverse event (AE) (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2662046

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022983

gering
Staat
TN
Alter
51,0
Geschlecht
M
Eingang
27.07.2023
Impfdatum
25.07.2023
Beginn
25.07.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered No adverse event

Symptomtext

Patient given first dose of MMR on 7/25/23. MMR had expired on 7/22/23. Patient was contacted and is to return to clinic in 4 weeks for repeat MMR. Patient did not have any adverse effects from vaccine. Expired medication was removed from freezer immediately.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2531138

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge u022983

gering
Staat
MN
Alter
57,0
Geschlecht
M
Eingang
14.12.2022
Impfdatum
13.12.2022
Beginn
13.12.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Wrong product administered

Symptomtext

Due to forming bad shortcut habits during covid nurse gave the wrong vaccine after relying on the system and not her own knowledge and normal processes for screening patients. Nurse gave the first chickenpox vaccine when it was supposed to be his second shingles vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None noted
Vorgeschichte
None noted
Andere Medikamente
None noted
Allergien
Penicillin
Vorherige Impfungen
-

VAERS 2512062

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022983

gering
Staat
IL
Alter
1,7
Geschlecht
F
Eingang
18.11.2022
Impfdatum
18.10.2022
Beginn
18.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE.; an improperly stored vaccine was administered to a patient / freezer out of temp range; This spontaneous report was received from a registered nurse and refers to a 20-month-old (reported as 19-month-old) female patient. She was a premature baby (36 weeks, 3118 grams birth weight). The patient had no medications, allergies, medical or surgical history. She had no siblings. On 18-OCT-2022, the patient was vaccinated with improperly stored doses of varicella virus vaccine live (oka/merck) (VARIVAX) (first dose) 0.5 milliliter via subcutaneous route in right vastus lateralis, lot #W005206, expiration date 14-FEB-2024, measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (first dose) via subcutaneous route in left vastus lateralis, lot #U022983, expiration date 22-JUL-2023 (exact dose was not reported), hib vaccine (HIB) (fourth dose) via intramuscular route in left vastus lateralis, lot #335N9, expiration date 25-MAY-2023 (exact dose was not reported), diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (DTAP) (fourth dose) via intramuscular route in right vastus lateralis, lot #LS444, expiration date 16-SEP-2023 (exact dose was not reported) and pneumococcal vaccine conj 13v (crm197) (PREVENAR 13) (fourth dose) lot #FMS700, expiration date 31-JUL-2024 (exact dose, injection site, route of administration were not reported) for prophylaxis. Administered doses of vaccines experienced the temperature excursion of 10.8 degrees Fahrenheit (F) for 18 hours 30 minutes. Freezer failed, the vaccines were moved to the back up location. Temperatures out of range multiple times due to odd cycle. The reporter was not aware of excursions until 21-OCT-2022. The digital data logger was involved in recording the temperature excursion details. No previous temperature excursion had occurred. There was no adverse event reported. No prescription drug treatment for the experience was required. The medication error occurred during storage in clinical practice. After excursion found, no further doses were given. The vaccines were not available for evaluation. The single use vaccines were used according to the instruction leaflet and were administered by trained healthcare professional in the private doctor's office/ hospital; purchased with private funds. This is one of several reports received from the same reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Premature baby 33 to 36 weeks
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2485131

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022983

gering
Staat
NY
Alter
5,0
Geschlecht
M
Eingang
21.10.2022
Impfdatum
23.09.2022
Beginn
23.09.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Inappropriate schedule of product administration No adverse event

Symptomtext

The child who came to our clinic on 9/23/22 for an MMR for school. Unfortunately, the clinic staff didn't see that they received a varicella on 8/29/22. So the MMR was given 25 days after the varicella, not the full 28 days; therefore is "NOT VALID"; given too early; no negative health outcomes.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
NKA
Vorherige Impfungen
-

VAERS 2464102

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022983

gering
Staat
IL
Alter
0,5
Geschlecht
M
Eingang
29.09.2022
Impfdatum
08.09.2022
Beginn
08.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration Product administered to patient of inappropriate age

Symptomtext

No side effects or adverse events reported; Caller stated they accidently administered MMR-II to a 6 month; it was given intramuscularly instead of subcutaneously; This spontaneous report was received from a nurse practitioner and refers to a 6-month-old male. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant medications included sterile diluent (STERILE DILUENT) (manufacturer unknown). On 08-SEP-2022, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection, 0.5 milliliter (1 dose), lot #U022983 rHA, expiration date: 22-JUL-2023, administered intramuscularly (Product administered to patient of inappropriate age, Incorrect route of product administration) for prophylaxis (strength was not provided). The vaccine was reconstituted with properly stored sterile diluent (MERCK STERILE DILUENT).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2394515

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022983

gering
Staat
MD
Alter
-
Geschlecht
U
Eingang
28.07.2022
Impfdatum
13.07.2022
Beginn
13.07.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported.; Caller is a medical assistant calling to report an adverse event for M-M-R II, VAQTA, and VARIVAX. Caller reports that the patient was administered all three vaccines on 13JUL2022, after they were exposed to a temperautre excursion.; This spontaneous report has been received from a medical assistant and refers to a patient of unknown gender and age. The patient's pertinent medical history, concurrent conditions, concomitant medications, and previous drug reactions or allergies were not reported. On 13-JUL-2022, the patient was vaccinated with improperly storage dose of measles, mumps, and rubella (Wistar RA 27-3) Virus Vaccine, Live (rHA) (M-M-R II) injection (lot number U022983 which has been verified to be valid, expiration date reported and validated as 22-JUL-2023), hepatitis A vaccine, inactivated (VAQTA) injection (lot number U038841 which has been verified to be valid, expiration date reported and validated as 06-MAR-2023), and varicella virus vaccine live (Oka/Merck) (VARIVAX) injection (lot number W002599 which has been verified to be valid, expiration date reported and validated as 24-JAN-2024). All of the vaccines were administered at a dose of 0.5 milliliters (ml) as prophylaxis (strengths, routes of administration, and anatomical sites of injection were not reported). The administered dose of measles, mumps, and rubella (Wistar RA 27-3) virus vaccine, live (rHA) (M-M-R II) and hepatitis A vaccine, inactivated (VAQTA) were stored at a temperature of 65 degrees Fahrenheit (F), during a time frame of 17 hours; the dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) was stored at a temperature of 67 degrees F, during a time frame of 17 hours (product storage error). There was no previous temperature excursion No additional adverse events were reported in the patient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2366371

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge u022983

gering
Staat
TX
Alter
1,8
Geschlecht
F
Eingang
20.07.2022
Impfdatum
13.06.2022
Beginn
13.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age

Symptomtext

Kinrix administered to patient outside recommended age range. No adverse events occurred to patient since incident. Parent was notified of incident on 6/17/22 and a correct catch up vaccine schedule has been set in place for patient. Remediation has been provided for ordering provider and administering staff member.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None
Vorgeschichte
N/A
Andere Medikamente
Cetirizine 5mg/5ml give 2.5ml PO daily
Allergien
None
Vorherige Impfungen
-

VAERS 2268415

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022983

gering
Staat
FL
Alter
-
Geschlecht
U
Eingang
10.05.2022
Impfdatum
14.04.2022
Beginn
14.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration No adverse event

Symptomtext

No additional AE reported.; Caller reports a dose of MMR II was administered intramuscularly. No additional AE reported. No PQC reported.; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, drugs reactions or allergies and concomitant medications were not reported. On 14-APR-2022, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant human albumin) (M-M-R II) lot # U022983, expiration date: 22-JUL-2023, 0.5 milliliter, intramuscular for prophylaxis (incorrect route of product administration). No additional adverse events reported. The lot # U022983 was verified to be valid number for measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant human albumin) (M-M-R II) (expiration date: 22-JUL-2023).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-